About DNAlytics
DNAlytics is a company based in Louvain-la-neuve (Belgium) founded in 2012. The company has 7 employees as of December 31, 2022. DNAlytics operates in a competitive market with competitors including MedGenome, Foundation Medicine, DNAnexus, Personalis and Veritas Genetics, among others.
- Headquarter Louvain-la-neuve, Belgium
- Employees 7 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
-$61.99 K (USD)-124as on Dec 31, 2022
-
EBITDA
$4.77 K (USD)-98as on Dec 31, 2022
-
Latest Funding Round
$56.22 K (USD), Grant
Sep 30, 2015
-
Investors
European Union
& 1 more
-
Employee Count
7
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of DNAlytics
Investors in DNAlytics
DNAlytics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for DNAlytics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DNAlytics
Investment portfolio details for DNAlytics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DNAlytics
Detailed financials for DNAlytics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dnalytics Comparisons
Peer comparison for DNAlytics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DNAlytics
DNAlytics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedGenome, Foundation Medicine, DNAnexus, Personalis and Veritas Genetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| Locked | Locked | Locked |
Genetic testing products for health risks and traits are offered.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
Detailed competitors of DNAlytics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dnalytics
Complete news archive for DNAlytics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DNAlytics
DNAlytics was founded in 2012 and raised its 1st funding round 3 years after it was founded.
DNAlytics is headquartered in Louvain-la-neuve, Belgium.
As of Dec 31, 2022, the latest employee count at DNAlytics is 7.
DNAlytics is a UCLouvain spin-off that bases its activities on a data mining technology platform. Based on this technology platform, DNAlytics covers the whole development of data-driven personalized medicine solutions, from RD to market access. DNAlytics business model spans two offerings: a data mining consultancy service (prognosis, diagnosis, theranosis, patient stratification and clinical trial support) and the development of a data-driven personalized medicine product pipeline (rheumatology and oncology). Their first marketed product is RheumaKit, a solution for the differential diagnosis of patients with Undifferentiated Arthritis. The solution is CE-marked for differential diagnostic application, while theranostic applications are in development. It also develops andor maintains the following software-REED - Rapid and Easy Evaluation of Datasets, LiblineaR - a software library for very large data sets classification and regression, jForest - a general framework for Machine Learning implementing tree ensemble based classification methods, and BLISS - Biomarker List Interpretation Simple Software.
DNAlytics's top competitors include DNAnexus, Foundation Medicine and MedGenome.
DNAlytics has 2 investors. Key investors include European Union, and EIC Fund.